ADIPOQ and obesity due to melanocortin 4 receptor deficiency: Adiponectin is shown to be decreased in plasma in obesity, insulin resistance and type 2 diabetes, while adiponectin supplementation is shown to ameliorate insulin resistance and impaired glucose tolerance in mice16–19.